Intrinsic Value of S&P & Nasdaq Contact Us

Semler Scientific, Inc. SMLR NASDAQ

NASDAQ Capital Marke • Healthcare • Medical - Devices • US • USD

SharesGrow Score
88/100
6/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$40.00
+96.8%

Semler Scientific, Inc. (SMLR) is a publicly traded company in the Healthcare sector, operating within the Medical - Devices industry. The company is headquartered in Santa Clara, CA, United States. The current CEO is Douglas Murphy-Chutorian.

SMLR has IPO date of 2014-02-21, 79 full-time employees, listed on the NASDAQ Capital Marke, a market capitalization of $310.75M.

About Semler Scientific, Inc.

Semler Scientific, Inc. provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition. Its products serve cardiologists, internists, nephrologists, endocrinologists, podiatrists, and family practitioners, as well as healthcare insurance plans, integrated delivery networks, independent physician groups, and companies contracting with the healthcare industry, such as risk assessment groups. The company offers its products through salespersons and distributors. Semler Scientific, Inc. was incorporated in 2007 and is headquartered in Santa Clara, California.

📍 2340-2348 Walsh Avenue, Santa Clara, CA 95051 📞 877-774-4211
Company Details
SectorHealthcare
IndustryMedical - Devices
CountryUnited States
ExchangeNASDAQ Capital Marke
CurrencyUSD
IPO Date2014-02-21
CEODouglas Murphy-Chutorian
Employees79
Trading Info
Current Price$20.33
Market Cap$310.75M
52-Week Range14.885-65.98
Beta1.32
ETFNo
ADRNo
CUSIP81684M104
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message